The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...

Ellipses Pharma Ltd. has agreed to in-license global rights to GENA-104, a first-in-class immuno-oncology monoclonal antibody ...

Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

Americans may be walking around with bird flu − and not even know it. President Donald Trump's next round of tariffs are ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

A new CDC report found evidence of previous bird flu infection in veterinary practitioners who work with cattle and who did ...

Three dairy veterinarians, including one who worked only in states with no known bird flu outbreaks in cows, had recent, ...